Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MERINO II: Meropenem vs Piperacillin-Tazobactam for AmpC Bloodstream Infections
NCT02437045Phase 4Completed
- Sponsor
- The University of Queensland
- Start
- Apr 2015
- Primary completion
- Dec 2020
- Modality
- Irreversible Covalent Inhibitors
- Countries
- 2
01
Overview
A Phase 4 trial of piperacillin + tazobactam in bloodstream infection (BSI), sponsored by The University of Queensland. Started Apr 2015; status: completed.
02
Drugs
piperacillin + tazobactam
03
Conditions
bloodstream infection (BSI)
Beyond the preview
Go deeper on NCT02437045.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02437045.